Dual biologic therapy with Vedolizumab and Ustekinumab for refractory Crohn's disease in children

Gadi Howard, Dror Weiner, Itzhak Bar-Or, Arie Levine*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dual biologic therapy with Vedolizumab and Ustekinumab for refractory Crohn's disease in children'. Together they form a unique fingerprint.

Medicine & Life Sciences